E-Paper
Sign In
Sat, Dec 13, 2025 | Jumada al-Thani 23, 1447 | Fajr 05:33 | DXB 
24.1°C
iPhone | iPad
Android
UAE to introduce nasal spray flu vaccine for first time: Emarat Al Youm
The vaccine covers the same strains approved annually as the injectable vaccine, and is suitable for those between 2 an 49 years old
For the first time, a nasal spray flu vaccine option will be available in a number of public and private healthcare centres and hospitals in the UAE, Emarat Al youm reported citing the country's Ministry of Health and Prevention
As part of the approved vaccination options for the current flu season, the Ministry said the needle-free option aim at expanding safe and effective immunization options for the community, and increasing vaccination coverage rates.
Recommended For You
The vaccine covers the same strains approved annually as the injectable vaccine, but it relies on a live attenuated virus (weekend virus) and is administered without needles, making it a suitable option for children and for those who fear injections, for healthy individuals aged 2 to 49.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
It first received approval from the US Food and Drug Administration (FDA) in 2003 for ages 5 to 49, before the approval was extended in 2007 to include children aged 2 to 5, said Dr. Nada Al Marzouqi, Director of the Public Health and Prevention Department at the Ministry of Health and Prevention.
She clarified that the vaccine is designated for healthy individuals aged 2 to 49, in line with approved clinical guidelines, and that consulting a physician is essential to determine the most appropriate option for each person.
The Ministry identified six groups for whom this vaccine is not recommended:
Children under 2
Adults aged 50 and above
Pregnant women
Individuals with immune disorders
Some people with certain chronic diseases
Those in close contact with individuals suffering from severe immunodeficiency
She also explained that in such cases, the injectable vaccine or other options determined by the physician are preferred, emphasising that the type of vaccine is always chosen to ensure the highest levels of safety and effectiveness in accordance with national and international guidelines and regulations.
The Ministry confirmed that the vaccine is registered in the UAE and subject to pharmaceutical oversight by the relevant authorities, and is approved by several global bodies including the US Food and Drug Administration (FDA), the World Health Organisation (WHO), and the European Medicines Agency (EMA).
All side effects and vaccine effectiveness are monitored in the UAE through the pharmacovigilance programme, as part of an integrated system that follows the safety and quality of medicines and vaccines in the country.
Don’t just scroll. Know it all. Sign up for your daily UAE news fix.
Get the top stories of the day right in your inbox.
